We describe here the isolation of chicken PAX6 and PAX7 as members of the PAX gene family expressed in late stages of chick nervous system development. By generating monoclonal antibodies against these PAX molecules, we analyzed their protein distributions in the CNS, neural crest cells and muscle precursor cells. Our detailed description of protein distributions revealed several new features of PAX expression patterns. In particular, PAX6 and PAX7 are expressed in restricted regions in the CNS during early stages. In contrast, at later stages the expression becomes localized to subsets of postmitotic cells in further restricted regions. Such a transition from region-specific expression to cell-specific expression suggests two different roles of these PAX molecules in development: the regionalization and subdivision of the nervous system during early stages, and the differentiation of specific cell populations during late stages. 0 1997 Elsevier Science Ireland Ltd.
Introduction
Recent studies of developmental control genes originally identified in the fruit fly Drosophila melanogaster have shown that many of these genes have homologues in vertebrates and have localized expression patterns during the development of the vertebrate nervous system (He et al., 1989; Kessel and Gruss, 1990; Gruss tid Walther, 1992; Chalepakis et al., 1993; Puelles and Rubenstein, 1993; Boncinelli, 1994; Keynes and Krumlauf, 1994; Rubenstein and Puelles, 1994) . Since many of these genes encode known or putative transcription factors and contain DNA-binding domains such as homeo domains and paired domains, it is likely that they control the expression of downstream target * Corresponding author. Skirball Institute of Biomolecular Medicine, New York University Medical Center, 540 First Avenue, New York, NY 10016, USA. e-mail: i45526a@nucc.cc.nagoya-u.ac.jp gehes whose products have important functions in the development of vertebrates.
Pax genes encode a family of transcription factors that have a conserved 12%amino acid DNA-binding domain, the paired domain (Bopp et al., 1986; Walther et al., 1991; Chalepakis et al., 1992) . Members of the pax gene family have been identified in mouse, human, zebrafish, chick, quail, frog and several other invertebrate species such as Drosophila melanogaster and Caenorhabditis elegans (Quiring et al., 1994; Chisholm and Horvitz, 1995; Zhang and Emmons, 1995) . All pax genes with the exception of Pax-l and Pax-9 are expressed in the developing vertebrate neural tube and brain. Expression domains often coincide with morphological boundaries in the embryonic nervous system, suggesting a role in early regionalization (Krauss et al., 1991; Chalepakis et al., 1993) . In addition, three members of the pax gene family have been shown to be disrupted by spontaneous mutations in mice and humans (reviewed by Gruss and Walther, 1992; Mansouri et al., 1994) : are mutated in undulated (Balling et al., 1988) , splotch (Epstein et al., 1991) and smalE eye mice (Hill et al., 1991) , respectively. Targeted disruption of Pax-2, Pax-4, Pax-SBSAP and Pax-7 caused abnormalities in urogenital system (Torres et al., 1995) , pancreas (Sona-Pineda et al., 1997) , posterior midbrain (Urbanek et al., 1994) and cephalic neural crest cell derivatives (Mansouri et al., 1996) , respectively. These findings suggest that the pan molecules have important and indispensable roles in development. Furthermore, the expression of Pax genes has been observed not only in early stages, but also in later stages of brain development (Chalepakis et al., 1993; Stoykova and Gruss, 1994) , suggesting that the pax family may have a role in later development of the nervous system when neurons differentiate and develop synaptic connections.
We are interested in the mechanisms directing the differentiation of particular neuronal cell groups in the brain, events that occur in later stages of nervous system development. Studies on the pax gene family prompted us to survey members of the pax gene family that are expressed in later stages of chick brain development. Two members of the pa gene family, PAX6 and PAX7, were found to be expressed abundantly during later stages in the brain. Previous studies have described the expression pattern of these pax genes using in situ hybridization in the mouse, zebrafish, quail and chicken (Jostes et al., 1990; Krauss et al., 1991; Walther and Gruss, 1991; Martin et al., 1992; Puschel et al., 1992; Li et al., 1994; Stoykova and Gruss, 1994; Stoykova et al., 1996) , and using pax-6 antibody in the zebrafish (Macdonald et al., 1994; Amirthalingam et al., 1995) . However, a detailed analysis of the distribution of PAX6 and PAX7 proteins in later stages of development has not yet been performed.
We have generated monoclonal antibodies against PAX6 and PAX7 molecules, and determined the precise spatial and temporal distribution of these proteins 
PAX-7
PO OP I-ID AfltiiWl during chick development. In the CNS, these PAX proteins are expressed in restricted regions during early stages. In contrast, at later stages expression becomes localized to subsets of postmitotic cells in further restricted regions. On the basis of these observations, we discuss the possible involvement of PAX6 and PAX7 in different phases of neuronal development: early in the regionalization and subdivision of brain regions, and late in the differentiation of specific neuron populations. In addition, PAX7 expression is observed in a population of head neural crest cells and limb muscle precursor cells, suggesting a potential role for PAX7 in the development of these regions.
Results

2.1.
Isolation of PAX6 and PAX7 cDNAs and production of monoclonal antibodies RT-PCR was used to obtain cDNA fragments of the chick PAX genes. To identify members of the PAX gene family involved in later development of the nervous system, we screened an E9 chick brain cDNA library under a reduced hybridization stringency. All positive clones corresponded to either PAX6 or PAX7, suggesting that these PAX genes may be abundantly expressed in the chick brain at later stages of development. Complete nucleotide sequences of full-length cDNAs encoding PAX6 and PAX7 were determined (see GSDB, DDJB, EMBL and NCBI nucleotide sequence databases with the accession numbers D87837 for chick PAX6 and D87838 for chick PAX7; Fig. 1A ). The predicted amino acid sequence of chick PAX6 is strikingly conserved with those of mouse (99.3%) and zebrafish (95.8%). Chick PAX7 sequence is also highly conserved with mouse Pax-7 (97.2%) and human PAX7 (91.4%), but
B
PAX6
PAX7 kD 1 2 3 4 5 6
Fig. 1. cDNA structure of chick PAX6 and PAX7, and production of monoclonal antibodies. (A) cDNA structure of chick PAX6 and PAX7. The paired domains (PD) are shown by hatched boxes, and the homeo domains (HD) are shown by stippled boxes. The octapeptide (OP) of PAX7 is indicated by the black bar between the paired and homeo domains. The regions used as antigens to generate antibodies are shown by the thick lines. (B) Western blot was performed against nuclear proteins from El0 chick retina (lanes l-3) and tectum (lanes 4-6). Tissues were collected from 20 embryos, and nuclei were dissolved in about 2 ml of sample buffer containing sodium dodecyl sulfate. Aliquots of 10 ~1 (lanes 1 and 4), 5 ~1 (lanes 2 and 5) and 2 ~1 (lanes 3 and 6) were elecrophoresed. The anti-PAX6 antibody detects two major (48 and 46 kDa) and two minor (40 and 38 kDa) products, and the anti-PAX7 antibody two major (55 and 53 kDa) and one minor (50 kDa) product.
has C-terminal deletion (22 amino acids) and extension (32 amino acids) compared with the human PAX7 (Schafer et al., 1994) . These differences in length may be due to alternative splicing of the chick PAX7 mRNA, suggesting the presence of distinct isoforms.
In the mouse, it is known that the amino acid sequence and expression of Pax-7 are closely related with those of Pax-3 (Jostes et al., 1990; Goulding et al., 1991; To analyze the protein distribution of PAX6 and PAX7 in the developing nervous system, antibodies were generated and . To verify the specificity of the anti-PAX7 by immunizing mice with recombinant proteins. The anti-PAX6 and PAX7 antibodies labeled chick tissues in a pattern antibody, we examined PAX3 mRNA and PAX7 protein on similar to that reported in the mouse, zebrafish and chick, suggesting that the antibodies specifically recognize PAX6 the same tissue sections. The result showed that some and PAX7 proteins. It has been reported that Pax-6 in the mouse and quail has multiple isoforms (Walther and Gruss, PAX3-expressing cells were not stained by the PAX7 anti-1991; Carriere et al., 1993) . In the chick, the anti-PAX6 antibody detects two major and two minor products in Wesbody. Considering that the PAX3 probe is long enough to tern blot analysis (Fig. lB) , suggesting that PAX6 isoforms exist in the chick and that the PAX6 antibody recognizes detect PAX3 isoforms, the data suggest that the PAX7 antithese isoforms.
body does not react with PAX3 proteins (data not shown). In addition, the anti-PAX7 antibody detects at least three products (two major and one minor) in Western blot analysis (Fig. 1B) . These products may correspond to the possible PAX7 isoforms described above.
2.2. Early expression of PAX6 and PAX7 2.2.1. PAX7 expression in head neural crest cells
In stage 10 embryos, PAX7 is expressed in a population of cranial neural crest cells migrating from the mesencephalon, the 1st rhombomere ( Fig. 2A) and from the 3rd and 5th rhombomeres (data not shown). PAX7+ neural crest cells from the 3rd and 5th rhombomeres migrate caudally to the 2nd and 3rd branchial arches, respectively (data not shown), whereas, the PAX7+ neural crest cells from the mesencephalon and the 1st rhombomere migrate in the anterior direction, passing over the eye primordium toward the frontonasal mass (Fig. 2B ). These cells settle in the lateral nasal prominence and in a region around the pigmented epithelium of the eye. The region occupied by these PAX7+ cells has a sharp posterior boundary at the anterior-posterior midline of the eye (Fig. 2C ). These cells presumably differentiate into mesenchymal cells (Fig. 3F, H) . It is known that the neural crest cells from the mesencephalic roof also contribute to the maxillary and mandibular arches (Lumsden et al., 1991; Serbedzjia et al., 1992; Osumi-Yamashita et al., 1994) . However, PAX7 is not expressed in the neural crest cells migrating to the maxillary and mandibular processes.
Thus, PAX7 is expressed in a subset of head neural crest cells that migrate to specific regions, suggesting a role of PAX7 in the specification and/or migration of a subset of head neural crest cells.
2.2.2. PAX7 expression in the somites and muscle precursor cells
In stage lo-11 embryos a uniform PAX7 expression is seen in the newly formed somites (data not shown). By stage 14, PAX7 expression is restricted to cells in the dorsal somites, the presumptive dermomyotomes ( Fig. 3B) . At stage 18, PAX7 is strongly expressed in myotomes and by myoblast cells migrating and forming the trunk and limb muscle precursors (Fig. 3D ), suggesting that PAX7 may have a role in the differentiation of both the trunk and limb muscles.
Consistent with previous in situ hybridization studies (Walther et al., 1991; Puschel et al., 1992; Li et al., 1994; Grindley et al., 1995) , PAX6 expression is seen in almost all cells of the eye primordium including the optic cup, developing lens and surface epithelium surrounding the lens placode in stage 14 embryos (Fig. 3E ). This observation supports the proposed role of PAX6 in the early specification 2.2.3. PAX6 expression in the eye primordium of the eye primordium (Halder et al., 1995) . At stage 24, when retinal neurons begin to differentiate, PAX6 expression disappears in the pigmented epithelium and is downregulated in the neural retina and differentiated lens cells (data not shown). However, after stage 24 PAX6 expression is elevated during the development of the retina (see Section 2.4).
PAX6 and PAX7 expression in the spinal cord
Consistent with earlier studies (Jostes et al., 1990; Walther et al., 1991; Goulding et al.. 1993 ) the expression of PAX6 and PAX7 begins around stage 10 in the neural tube. PAX7 is expressed in the alar and roof plate with a sharp ventral boundary corresponding to the sulcus limitans in stage 14 embryos (Fig. 3B ). PAX6 protein is detected in a band of cells in the mid-lateral neural tube in stage 18 embryos (Fig. 3A) . The dorsal and ventral boundaries of PAX6 expression are vague when compared to those of PAX7. PAX6 expression extends dorsally and ventrally to the sulcus limitans and overlaps with the PAX7+ domain. Thus, the overlapping expression of PAX6 and PAX7 subdivides the spinal cord along the dorsal-ventral axis, suggesting a role for PAX6 and PAX7 in the early subdivision of the spinal cord. From stage 18 onwards, both PAX6 and PAX7 are restricted to the ventricular zone (Fig. 3C, D ).
PAX6 and PAX7 expression during development of the brain
In the brain, the expression of PAX6 and PAX7 begins around stage 10 ( Fig. 2A ; data not shown). PAX7 is of Development 66 (-1997) expressed continuously along the roof plate through stage 14 ( Fig. 3F ), at which time PAX6 expression is detected in the dorsal prosencephalon, excluding the roof plate ( Fig.  3E ). Consequently, PAX6 and PAX7 are complementarily expressed in the prosencephalon.
As development proceeds to stage 24, PAX6 is expressed in the ventricular zone of the telencephalon and in parts of the diencephalon including the epithalamus, dorsal thalamus, ventral thalamus and pretectum (Fig. 3G, I ). PAX7 expression is restricted to the roof plate of the telencephalon in the anterior region and to the epithalamus, pretectum and tectum in the posterior region ( Fig. 3H and Fig. 4A ). In the telencephalon, both PAX6 and PAX7 are expressed in a narrow region between the roof and alar plates (Fig. 3G,  H) , suggesting the presence of subdivision in this region. In the diencephalon, the boundary of PAX6 and PAX7 expression respects some prosomere boundaries as proposed in the mouse (Fuelles and Rubenstein, 1993; Stoykova and Gruss, 1994; Stoykova et al., 1996) . The boundary of the PAX6+ domain coincides with the boundary between p3 and p4, the boundary between the ventral thalamus and the hypothalamus (Fig. 31) , and the boundary of the PAX7+ domain coincides with the boundary between pl and p2, the boundary between the pretectum and the dorsal thalamus (Fig. 4A) . However, in other regions PAX6 and PAX7 expression does not respect the prosomeric boundaries: PAX6 and PAX7 expression partially overlaps in the epithalamus and pretectum ( Fig. 4A ; data not shown), and PAX6 is not expressed in the ventral part of the dorsal thalamus (Fig.  31 ). These observations suggest that the diencephalon is divided by the expression of PAX6 and PAX7 into smaller units than the prosomeres, suggesting a role of PAX6 and PAX7 in the subdivision of the prosomeres.
Later in development, the expression of PAX6 and PAX7 becomes localized to post-mitotic cells in restricted domains in the brain (Fig. 31 and 5) . At stage 35, PAX6 expression in the telencephalon is restricted to the ventricular zone and decreases with age ( Fig. 5B ). In the rostra1 diencephalon PAX6 protein distribution is observed in a group of dispersed cells in the septum, olfactory tuberculum ( Fig. 5A ) and paleostriatum (Fig. 5B ). In the ventral thalamus, PAX6' cells mainly contribute to a single nucleus, probably the nucleus decussationis supraopticae ventralis (Kuhlenbeck, 1936) (Fig. 5F ). PAX7 is strongly expressed in the differentiating epiphysis from stage 35 onward (Fig. 5C,E) . More caudally, the expression domains of PAX6 and PAX7 overlap in the ventricular zone of the pretectum (Fig. 5G,H) , whereas PAX6 and PAX7 appear to be expressed in different populations of post-mitotic cells of the pretectum: PAX6 in the rostral-medial pretectum, and PAX7 in the caudal-lateral pretectum ( Fig. 5G-J) . In the mesencephalon, PAX7 is expressed in the laminae of the tectum ( Fig. 5K ; see below) and in cells in some nuclei of the ventral mesencephalon, possibly the nucleus lemnisci lateralis ventralis, raphe nucleus (Fig. 5K) , and nucleus interpeduncularis (data not shown). Thus, the expression of PAX6 and PAX7 becomes localized to groups of post-mitotic cells, suggesting a role for these PAX molecules in the differentiation of specific neuronal cell groups in the brain.
2.4. PAX6 expression during the development of the retina As described above, the expression of PAX6 is transiently down-regulated in the retina around stage 24. Between stages 24 and 36, a dramatic increase in PAX6 expression occurs (Fig. 6A) . At stage 24, a small number of cells at the vitreal surface of the retina, possibly the differentiating ganglion cells, begins to express a high level of PAX6 protein (data not shown). As development proceeds, the number of PAX6* cells increases (Fig. 7A) . The PAX6+ cells begin to form layers by stage 35 (Fig. 7B) . By stage 37, when the retinal layers are well established, PAX6 is strongly expressed in the ganglion cells, amacrine cells and horizontal cells, but not in the bipolar cells and photoreceptor cells (Fig. 7C, D) . This observation suggests a role of PAX6 in the differentiation of ganglion, amacrine and horizontal cells during the later development of retina.
PAX7 expression during the development of the optic tectum
From stage 37 onward, PAX7 expression is restricted to the optic tectum and epiphysis, and down-regulated in other areas. Northern blot hybridization shows that PAX7 expression is maintained at a similar level in the tectum from stages 24 to 36 (Fig. 6B ). In contrast, the level of PAX3 mRNA markedly decreases between stages 24 and 36 (Fig. 6C) .
Immunostaining indicates that PAX7 is expressed in differentiating neuronal cells forming the characteristic laminar structure of the tectum (Fig. 8) . At stage 27, when no laminar structure has yet formed, a subset of cells in the tectum strongly expresses PAX7 (Fig. 8A) . As the formation of laminae begins at stage 31 (Fig. 8B) , PAX7' neurons migrate radially toward the pia of the tectum (Fig. 8B) , and concentrate in one layer, the stratum griseum superficiale (SGFS), (LaVail and Cowan, 1971 ) from stage 37 onward (Fig. 8C, D) . The SGFS is known to be the target site for the retinal axons. PAX7' cells are seen in two deeper laminae, the SGC (the stratum griseum centrale) and SAC (the stratum album centrale), and are likely to be the migrating cells since PAX7+ cells do not concentrate in these laminae. These observations suggest that the neurons destined to reside in the SGFS lamina are specified at an early stage, before neuronal differentiation has occurred, and that PAX7 may be involved in the specification and development of the SGFS neurons during tectal development. of Development 66 (1997) 
PAX6 and PAX7 expression during the development of the cerebellum
In stage 35 embryos, both PAX6 and PAX7 are expressed in the external granular cell layer of the cerebellum primordium (Fig. 9A, B) . As development proceeds, the number of PAX6' cells increases in the granular cell layer (Fig. 9C, E) . Since the granular cells in the cerebellum are known to derive from the external granular cell layer (Jacobson, 1991) , we propose that the granular cells in the cerebellum express PAX6.
PAX7 expression in the external granular cell layer gradually becomes localized to unidentified cells at the outer limit and disappears by stage 40 (Fig. 9D) . In contrast, the PAX7+ cells from the 4th ventricle become distributed in the granular and Purkinje cell layer by stage 40 (Fig. 9D) and localized to the Purkinje cell layer at stage 43 (Fig. 9F , G). Close examination shows that these PAX7+ cells are not the Purkinje cells themselves, but surrounding cells (Fig.  9F) , most likely the Bergman glial cells whose fibers act as a guide for migrating granule cells (Jacobson, 1991) . In summary, PAX6 and PAX7 are expressed in subsets of differentiated cells in the cerebellum, suggesting a role of PAX6 and PAX7 in the differentiation of specific cell populations in the cerebellum.
Discussion
We have identified PAX6 and PAX7 as candidate regulators that may be involved in later stages of development of the CNS. Several new features of PAX6 and PAX7 expression in the chick CNS, head neural crest and muscle precursor cells were revealed antibodies. using specific monoclonal 3.1. Role of PAX7 in head neural crest cells and muscle precursor cells
We detected PAX7 expression in a subset of neural crest cells that migrate from the mesencephalon and lst, 3rd and 5th rhombomeres. The expression pattern is consistent with that for the mouse Pax-7 reported by Mansouri et al. (1996) . The neural crest cells from the mesencephalic region are known to contribute to the frontonasal mass, maxillary process and mandibular process (Lumsden et al. 1991; Serbedzjia et al., 1992; Osumi-Yamashita et al., 1994) . However, PAX7+ neural crest cells migrate only to the frontonasal mass and a region around the pigmented epithelium of the eye, suggesting a role of PAX7 in the migration and/or determination of a subset of head neural crest cells. In addition, PAX7 expression begins early, before the onset of neural crest cell migration, suggesting that the head neural crest cell populations may be specified early before their migration.
We did not detect PAX7 expression in the trunk neural crest cells. In contrast, it has been reported that the mouse Pax-3 is widely expressed in the neural crest cells in the head (Mansouri et al., 1996) and in the trunk region (Goulding et al., 1991) . Therefore, a functional redundancy between Pax-3 and Pax-7 in the head region may account for the observations that only trunk crest derivatives are lost in splotch mice (Epstein et al., 1991) , and that Pax-7 mutant mice show a mild disgenesis in the cephalic neural crest derivatives (Mansouri et al., 1996) . PAX7 protein expression was observed in precursor cells of both limb and trunk muscles until the stage at which precursor cells form the myotube, suggesting a role of PAX7 in early muscle development. In the mouse, it has been reported that Pax-7 mRNA expression is down-regulated in the limb muscle precursors (Goulding et al., 1994) A. Kawakami et al. /Mechanisms of Development 66 (1997) limb muscle precursor cells suggests that the down-regulation of Pax-7 mRNA in the mouse premigratory limb muscle precursors may not be a prerequisite for the migration of these cells. Since both PAX3 and PAX7 are strongly expressed in the limb and trunk muscle precursor cells, both PAX3 and PAX7 may have an important, possibly redundant, role in the development of limb and trunk muscle.
Role of PAX6 and PAX7 in the spinal cord
In the neural tube, PAX6 and PAX7 are expressed in the mid-lateral and dorsal half of the spinal cord, respectively. The expression domains overlap each other, suggesting a role in the subdivision of the spinal cord. It has been reported that the notochord suppresses PAX3 and PAX6 gene expression in the spinal cord (Goulding et al., 1993) . Recently, it has been demonstrated that sonic hedgehog suppresses PAX7 expression in the ventral neural tube and produces PAX7-progenitor cells which are destined to differentiate into ventral cell types (Ericson et al., 1996) . Moreover, activin is reported to suppress PAX6 expression in spinal cord explants (Pituello et al., 1995) . Thus, secreted molecules that induce or suppress PAX6 and/or PAX7 expression may be responsible for defining the domains of PAX gene expression and establishing the dorsal-ventral regional cell identities in the spinal cord. Different PAX genes would respond differentially to these inducing and/ or repressing factors.
Role of PAX6 and PAX7 in brain development
In early stages of brain development, chick PAX6 and A. Kawakami et al. /Mechanisms of Development 66 (1997) 119-130 127 FAX7 are expressed in a region-specific manner, and expression is similar to that seen in zebrafish and mouse (Krauss et al., 1991; Stoykova and Gruss, 1994) . Borders of PAX6 and PAX7 expression coincide with some prosomeric boundaries in the diencephalon (Puelles and Rubenstein, 1993) . However, in other regions we observed that the expression of PAX6 and PAX7 does not respect the prosomerit boundaries.
PAX6 is not expressed in the dorsal region of the dorsal thalamus. PAX6+ domains overlap with PAX7+ domains at the junction of the alar and roof plates of the telencephalon, and in the epithalamus and pretectum of the diencephalon. Thus, the expression of PAX6 and PAX7 divides the chick telencephalon and diencephalon into smaller units than the prosomeres, suggesting that PAX6 and PAX7 may have a role in the subdivision of the brain regions.
In later stages of development, the expression of PAX6 and PAX7 becomes localized to subsets of postmitotic cells in restricted regions of the brain: PAX6 is expressed in subsets of post-mitotic cells of the diencephalon (the olfactory tuberculum, paleostriatum and ventral thalamus), pretectum and cerebellum, and PAX7 in post-mitotic cells of the epiphysis, pretectum, tectum, some nuclei in the mesencephalon and cerebellum. Our analysis of protein distribution in the chick is consistent with the in situ hybridization analysis in mouse , but goes beyond that study to show that PAX6 and PAX7 are expressed in subsets of cells in restricted brain regions. This suggests a role for PAX6 and PAX7 in the differentiation of specific groups of cells in the brain.
Taken together, the expression pattern of PAX6 and PAX7 suggests that these molecules have two different roles in early and late development:
early in development, they function in the regionalization and subdivision of the nervous system, and later they are involved in the differentiation of subsets of brain cells.
Role of PAX6 in the development of retina
It has been shown that Pax-6 is involved in a number of mutations affecting eye formation in both mouse, human and Drosophila (Hill et al., 1991; Ton et al., 1991; Quiring et al., 1994) , suggesting a role of Pax-6 in the early formation of the eye primordium. Supporting this notion, the misexpression of Pax-6 in Drosophila causes ectopic eye formation (Halder et al., 1995) . In our study, PAX6 expression was detected in almost all cells of the chick eye primordium during early stages, supporting the idea that Pax-6 is involved in the early specification of cells constituting the eye.
In contrast, in subsequent stages PAX6 is transiently down-regulated, then strongly re-expressed in cells differentiating into the ganglion cells, amacrine cells and horizontal cells in the retina, suggesting a role for PAX6 in the differentiation of these cell types. Furthermore, the expression in individual cells is very high compared with that of early stages, suggesting that a high amount of PAX6 protein may be required for the differentiation of ganglion, amacrine and horizontal cells. Since PAX6 expression in the retina can be divided into early and late phases, PAX6 may have two different roles in eye development: first, the early specification of eye primordium, and second, the late differentiation of ganglion, amacrine and horizontal cells in the retina. Supporting the role of Pax-6 in the later retina development, malformations of laminae have been observed in the retina of heterozygous Pax-6 mutant mice and rats (Hogan et al., 1988; Osumi-Yamashita et al., 1997) .
Conclusions
In the CNS and retina PAX6 and PAX7 expression is consistently observed in two different phases of nervous system development. In early stages, these molecules are expressed in restricted regions, whereas in later stages their expression becomes localized to subsets of cells in further restricted regions. Our observations suggest that these PAX proteins may function differently in early and late development. Though the function of PAX6 and PAX7 in later stages has not yet been fully analyzed, overexpression studies or conditional knock-out experiments might provide an approach to address these potential late functions.
Materials and methods
Isolation of chick PAX6 and PAX7
The following set of degenerate primers was used to amplify members of the chick PAX gene family. The primers were designed so that any paired box sequences would be amplified.
1F:
A(GA)(GTC)A(GA)(TC)(TC)(GT)GTC(GATC)-C(GT)GAT(TC)TCCCA Poly(A)+ RNA from E2-E6 chick embryos was used for the reverse transcription reaction, and an aliquot was used in an amplification reaction. PCR conditions: denaturation, 94°C for 4 min; amplification, 55°C for 1 min, extension, 72°C for 2 min x 25 cycles. Amplified products were randomly cloned and sequenced.
The PCR-amplified clones that had sequences similar to those of PAX6, PAXl/9, PAX2/5/8 and PAX3/7, respectively, were used as probes for subsequent library screening. Screening of 2 x lo6 phage clones of an E9 chick brain cDNA library at low stringency resulted in the isolation of 5 1 positive clones that were put into two classes corresponding to either PAX6 or PAX'/. Sequences were determined for the longest cDNA clones (clone p5 for PAX6 and px14 for PAX7).
Production of recombinant proteins and generation of monoclonal antibodies
The DNA region corresponding to amino acids l-223 of chick PAX6 (Fig. 1A) was PCR-cloned into the PET-3c expression vector (Rosenberg et al., 1987) . The DNA region corresponding to amino acids 352-523 of the chick PAX7 (Fig. 1A) was excised from the px14 clone by digestion with ApaI and Hind111 and cloned into PET-3c after making both ends blunt. Recombinant proteins were expressed and purified as described previously (Kawakami et al., 1990) , and dialyzed against 10 mM phosphate buffered saline, pH 7.5.
Aliquots of about 1 mg recombinant protein were emulsified in Freund's complete adjuvant and injected into Bdb/ c mice. At 2-week intervals the mice received two booster immunizations with 250 pg of the recombinant protein. At 4 days after the final immunization, spleen cells were fused with P3Ul myeloma cells. Hybridoma cells were screened by ELISA for immunoreactivity against the recombinant proteins. The ELISA plates were coated with 5 pg per well of the recombinant proteins diluted with 0.1 M carbonate buffer containing 0.5 M NaCl, pH 8.3. The candidate clones were further assayed by immunohistochemical staining of chick embryo sections.
Northern blot hybridization
The retina and tectum were collected on dry ice. Total RNAs were extracted and purified by the AGPC method (Chomzczynski and Sacchi, 1987) . Poly(A)+ RNAs were purified using an mRNA purification kit (Pharmacia) according to the manufacturer's instruction. Aliquots of 0.5 pg poly(A)+ RNAs were electrophoresed using 1.2% agarose gels containing formaldehyde and MOPS buffer (Lehrach et al., 1977) and blotted onto nylon membranes in 20 x SSC under vacuum aspiration (Pharmacia).
DNA fragments encoding amino acids l-223 of PAX6 and amino acids 275-524 of PAX7 were radiolabeled and used as probes. The PAX3 probe was excised from a PAX3 cDNA that was cloned from an E5 chick cDNA library. The PAX3 probe covered about 600 bases downstream to the XhoI site (Goulding et al., 1993 ) which corresponds to a part of the homeobox and all of the C-terminal region. The same regions of the PAX cDNAs were also used as probes for in situ hybridization.
Immunohistochemical procedures
Embryos were embedded in OCT compound (TissueTek, Miles Inc., Elkhart, USA), and sections (lo-20 pm thick) were cut and collected on poly-L-lysine-coated glass slides. Endogenous peroxidase activity was quenched with 6% hydrogen peroxide in methanol at room temperature for 30 min. After blocking with 5% skimmed milk in TBS (10 mM Tris-HCl, 130 mM NaCl, pH 7.5) for 30 min, the sections were incubated overnight with antibodies against PAX6 or PAX7 (1: 1000 dilution of 2 mg/ml stock solution with 1% skimmed milk in TBST). The secondary biotinylated anti-mouse antibody (1:200, Amersham) and streptavidin-HRP complex (ABC elite kit, Vectastain) were applied. HRP activity was detected with 0.025% diaminobenzidine (DAB) and 0.03% hydrogen peroxide in TBST. For whole-mount staining, the fixed and quenched tissues were incubated with 10% fetal calf serum in TBST plus 0.1% Triton X-100 (TBSTT) for at least 1 h, and with the primary antibody at 4°C overnight. After washing with TBSTT for 5 x 30 mintimes, the tissues were incubated with the secondary HRP-labeled anti-mouse antibody at room temperature for 3 h. After extensive washing and equilibration with 0.025% DAB in TBSTT, the HRP reaction was performed by adding H202 at a final concentration of 0.03%.
